214
Views
1
CrossRef citations to date
0
Altmetric
Polycystic ovary syndrome

Effect of orlistat during individualized comprehensive life-style intervention on visceral fat in overweight or obese PCOS patients

, ORCID Icon, , , , , & show all
Pages 676-680 | Received 17 Mar 2022, Accepted 09 Jun 2022, Published online: 20 Jun 2022

References

  • Dumesic DA, Oberfield SE, Stener-Victorin E, et al. Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr Rev. 2015;36(5):487–525. PMID: 26426951; PMCID: PMC4591526.
  • Barber TM, Hanson P, Weickert MO, et al. Obesity and polycystic ovary syndrome: Implications for pathogenesis and novel management strategies. Clin Med Insights Reprod Health. 2019;13:1179558119874042. Sep 9 PMID: 31523137; PMCID: PMC6734597.
  • Behboudi-Gandevani S, Ramezani Tehrani F, Rostami Dovom M, et al. Insulin resistance in obesity and polycystic ovary syndrome: systematic review and meta-analysis of observational studies. Gynecol Endocrinol. 2016;32(5):343–353. Epub 2016 Jan 6. PMID: 27052492.
  • Cooney LG, Lee I, Sammel MD, et al. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2017;32(5):1075–1091. May 1 PMID: 28333286.
  • Ilias I, Goulas S, Zabuliene L. Polycystic ovary syndrome: Pathways and mechanisms for possible increased susceptibility to COVID-19. World J Clin Cases. 2021;9(12):2711–2720. PMID: 33969054; PMCID: PMC8058679.
  • Shen N, Li X, Zheng S, et al. Automated and accurate quantification of subcutaneous and visceral adipose tissue from magnetic resonance imaging based on machine learning. Magn Reson Imaging. 2019;64:28–36. Epub 2019 Apr 18. PMID: 31004712.
  • Sobol W, Rossner S, Hinson B, 3rd, et al. Evaluation of a new magnetic resonance imaging method for quantitating adipose tissue areas. Int J Obes. 1991;15(9):589–599. PMID: 1960010.
  • Ruan X, Li M, Mueck AO. Why does polycystic ovary syndrome (PCOS) need long-term management? Curr Pharm Des. 2018;24(39):4685–4692. PMID: 30706800.
  • Beydoun HA, Beydoun MA, Hossain S, et al. Patterns of bariatric surgeries among U.S. women diagnosed with polycystic ovarian syndrome. J Womens Health (Larchmt). 2020;29(4):585–595. Epub 2020 Feb 20. PMID: 32077783; PMCID: PMC7366265.
  • Oguz SH, Yildiz BO. An update on contraception in polycystic ovary syndrome. Endocrinol Metab (Seoul). 2021;36(2):296–311. Epub 2021 Apr 15. PMID: 33853290; PMCID: PMC8090477.
  • Bansal AB, Al Khalili, Y, Orlistat. 2021 Nov 4. StatPearls [internet]. Treasure Island (FL): StatPearls Publishing.
  • Ruan X, Song J, Gu M, et al. Effect of diane-35, alone or in combination with orlistat or metformin in chinese polycystic ovary syndrome patients. Arch Gynecol Obstet. 2018;297(6):1557–1563. Epub 2018 Mar 30. PMID: 29602978.
  • China Working Group on problem of Obesity. Guidelines for the prevention and control of overweight and obesity in Chinese adults. J Nutr. 2004;26(1):1–4.
  • Li Y, Ruan X, Wang H, et al. Comparing the risk of adverse pregnancy outcomes of chinese patients with polycystic ovary syndrome with and without antiandrogenic pretreatment. Fertil Steril. 2018;109(4):720–727. Epub 2018 Mar 7. PMID: 29525688.
  • de Medeiros SF. Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome. Reprod Biol Endocrinol. 2017;15(1):93. PMID: 29216881; PMCID: PMC5721684.
  • Amiri M, Ramezani Tehrani F, Nahidi F, et al. Effects of oral contraceptives on metabolic profile in women with polycystic ovary syndrome: a meta-analysis comparing products containing cyproterone acetate with third generation progestins. Metabolism. 2017;73:22–35. Epub 2017 May 10. PMID: 28732568.
  • Panda SR, Jain M, Jain S, et al. Effect of orlistat versus metformin in various aspects of polycystic ovarian syndrome: a systematic review of randomized control trials. J Obstet Gynaecol India. 2018;68(5):336–343. Epub 2018 Jun 12. PMID: 30224835; PMCID: PMC6133796.
  • Patni N, Quittner C, Garg A. Orlistat therapy for children with type 1 hyperlipoproteinemia: a randomized clinical trial. J Clin Endocrinol Metab. 2018;103(6):2403–2407. PMID: 29659879; PMCID: PMC6456945.
  • Saleh A, ElFayoumi HM, Youns M, et al. Rutin and orlistat produce antitumor effects via antioxidant and apoptotic actions. Naunyn Schmiedebergs Arch Pharmacol. 2019;392(2):165–175. Epub 2018 Nov 21. PMID: 30465055.
  • Esmail VAW, Mohammed MO, Al-Nimer MSM. Short-term orlistat therapy improves fatty infiltration indices and liver fibrosis scores in patients with non-alcoholic fatty liver disease and metabolic syndrome. Arab J Gastroenterol. 2021;22(1):1–5. Epub 2021 Mar 2. PMID: 33664007.
  • Cohen JB, Gadde KM. Weight loss medications in the treatment of obesity and hypertension. Curr Hypertens Rep. 2019;21(2):16. PMID: 30747357; PMCID: PMC6415530.
  • Keevil BG, Adaway J. Assessment of free testosterone concentration. J Steroid Biochem Mol Biol. 2019;190:207–211. Epub 2019 Apr 7. PMID: 30970279.
  • Song J, Ruan X, Gu M, et al. Effect of orlistat or metformin in overweight and obese polycystic ovary syndrome patients with insulin resistance. Gynecol Endocrinol. 2018 May;34(5):413–417. Epub 2017 Nov 24. PMID: 29172796.
  • Khalil H, Ellwood L, Lord H, et al. Pharmacological treatment for obesity in adults: an umbrella review. Ann Pharmacother. 2020;54(7):691–705. Epub 2020 Jan 20. PMID: 31958967.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.